指南与共识衰弱、肌少症与跌倒老年综合评估

AWGS 2019肌少症诊断标准组合与社区老年人不良健康结局的关系

Combinations of Sarcopenia Diagnostic Criteria by Asian Working Group of Sarcopenia (AWGS) 2019 Guideline and Incident Adverse Health Outcomes in Community-Dwelling Older Adults.
指南 / 共识 · J Am Med Dir Assoc · 2023-05-17

本研究基于韩国衰弱与老龄化队列研究(KFACS),对1959名社区老年人进行2年随访,探讨AWGS 2019肌少症诊断标准不同组合与不良健康结局的关联。结果显示,低肌肉量合并低体能(尤其用SPPB评估)可预测移动残疾、跌倒、跌倒伴骨折及IADL残疾,而低肌肉量合并低握力则无显著关联。

要点

  • 低肌肉量+低体能增加移动残疾(OR 2.14)和跌倒(OR 1.74)风险。
  • 低肌肉量+SPPB低体能增加跌倒伴骨折(OR 2.53)和IADL残疾(OR 2.77)风险。
  • 低肌肉量+低握力与任何不良健康结局均无显著关联。

核心结论

  • 基于低肌肉量和低体能诊断的肌少症对社区老年人不良健康结局的预测价值更好。
  • 使用SPPB作为低体能诊断工具可能提高对跌倒伴骨折和IADL残疾的预测效度。

研究设计与样本

  • 韩国衰弱与老龄化队列研究(KFACS)的纵向分析,2年随访。
  • 纳入1959名社区老年人(女性52.8%,平均年龄75.9±3.9岁)。
  • 基线评估包括双能X线吸收法测四肢骨骼肌量、握力、常规步速、5次坐立试验和SPPB。
  • 采用多变量logistic回归分析不同肌少症诊断标准与2年后新发不良健康结局的关联。

主要发现

  • 444名参与者(22.7%)按AWGS 2019标准诊断为肌少症。
  • 低肌肉量+低体能增加移动残疾风险(OR 2.14,95%CI 1.35-3.38)和跌倒风险(OR 1.74,95%CI 1.21-2.49)。
  • 低肌肉量+SPPB低体能增加跌倒伴骨折风险(OR 2.53,95%CI 1.01-6.35)和IADL残疾风险(OR 2.77,95%CI 1.21-6.33)。
  • 低肌肉量+低握力与任何不良健康结局的发生均无关联。

关键数值与推荐

  • 肌少症诊断采用AWGS 2019标准。
  • 低肌肉量+低体能:移动残疾OR 2.14(95%CI 1.35-3.38),跌倒OR 1.74(95%CI 1.21-2.49)。
  • 低肌肉量+SPPB低体能:跌倒伴骨折OR 2.53(95%CI 1.01-6.35),IADL残疾OR 2.77(95%CI 1.21-6.33)。

临床怎么用

  • 在社区老年人中,采用低肌肉量合并低体能(尤其是SPPB评估)诊断肌少症可能有助于识别不良健康结局高风险个体。
  • 低肌肉量合并低握力与不良结局无显著关联,其预测价值有限。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to investigate the association between combinations of sarcopenia criteria by the Asian Working Group of Sarcopenia (AWGS) 2019 guideline and incident adverse health outcomes. DESIGN: Longitudinal analyses of a cohort study. SETTING AND PARTICIPANTS: We conducted prospective 2-year follow-up analyses (N = 1959) among community-dwelling older adults enrolled in the nationwide Korean Frailty and Aging Cohort Study (KFACS). METHODS: From the KFACS, 1959 older adults (52.8% women; mean age = 75.9 ± 3.9 years) who underwent assessments for appendicular skeletal mass using dual-energy X-ray absorptiometry, handgrip strength, usual gait speed, 5-times sit-to-stand test, and Short Physical Performance Battery (SPPB) at baseline were included. Participants with each adverse health outcome [mobility disability, falls, and instrumental activities of daily living (IADL) disabilities] at baseline were excluded for each corresponding analysis. Multivariable logistic regression was performed to examine whether sarcopenia defined by different diagnostic criteria was associated with incident adverse health outcomes after 2 years. RESULTS: A total of 444 participants (22.7%) were diagnosed with sarcopenia as defined by AWGS 2019. In the multivariable analysis, sarcopenia defined as both low muscle mass and low physical performance increased the risk of mobility disability (OR 2.14, 95% CI 1.35-3.38) and falls (1.74, 95% CI 1.21-2.49). Only the criterion defined as both low muscle mass and physical performance using the SPPB increased the risk of falls with fracture (2.53, 95% CI 1.01-6.35) and IADL disabilities (2.77, 95% CI 1.21-6.33). However, sarcopenia defined as both low muscle mass and low hand grip strength showed no associations with the incidence of any of the adverse health outcomes. CONCLUSIONS AND IMPLICATIONS: Our study suggests that the predictive value of adverse health outcomes for community-dwelling older adults is better when diagnosed with sarcopenia based on low muscle mass and physical performance. Furthermore, using the SPPB as a diagnostic tool for low physical performance may improve the predictive validity for falls with fracture and IADL disability. Our findings may be helpful for the early detection of individuals with sarcopenia who have a higher risk of adverse health outcomes.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Oh MH, Shin HE, Kim KS, et al. Combinations of Sarcopenia Diagnostic Criteria by Asian Working Group of Sarcopenia (AWGS) 2019 Guideline and Incident Adverse Health Outcomes in Community-Dwelling Older Adults. J Am Med Dir Assoc. 2023. PMID: 37209713. doi:10.1016/j.jamda.2023.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。